Editorial: The role of aspirin in non-arteritic anterior ischaemic optic neuropathy

Neuro-Ophthalmology

Volumn 34, Issue 1, 2010, Pages 1-5

  Hayreh, Sohan Singh ^a  

^a UNIVERSITY OF IOWA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID;

EDITORIAL; EMBOLISM; HUMAN; HYPOTENSION; ISCHEMIC OPTIC NEUROPATHY; NONARTERITIC ANTERIOR ISCHEMIC OPTIC NEUROPATHY; PATHOGENESIS; VISUAL IMPAIRMENT;

EID: 76449099767     PISSN: 01658107     EISSN: 1744506X     Source Type: Journal    
DOI: 10.3109/01658100903582811     Document Type: Editorial

References (33)

1. Hayreh SS. Ischemic optic neuropathy. Prog Retin Eye Res. 2009;28:34-62.
2. Hayreh SS, Jonas JB, Zimmerman MB. Nonarteritic anterior ischemic optic neuropathy and tobacco smoking. Ophthalmology. 2007;114:804-809.
3. Preechawat P, Bruce BB, Newman NJ, Biousse V. Anterior ischemic optic neuropathy in patients younger than 50 years. Am J Ophthalmol. 2007;144:953-960.
4. Sergott RC, Cohen MS, Bosley TM, Savino PJ. Optic nerve decompression may improve the progressive form of nonarteritic ischemic optic neuropathy. Arch Ophthalmol. 1989;107:1743-1754.
5. Hayreh SS. The role of optic nerve sheath fenestration in management of anterior ischemic optic neuropathy. Arch Ophthalmol. 1990;108:1063-1065.
6. Ischemic Optic Neuropathy Decompression Trial Research Group. Optic nerve decompression surgery for nonarteritic anterior ischemic optic neuropathy (NAION) is not effective and may be harmful. JAMA. 1995;273: 625-632.
7. Hayreh SS. The blood supply of the optic nerve head and the evaluation of it-myth and reality. Prog Retin Eye Res. 2001;20:563-593.
8. Hayreh SS. Blood flow in the optic nerve head and factors that may influence it. Prog Retin Eye Res. 2001;20: 595-624.
9. Hayreh SS, Joos KM, Podhajsky PA, Long CR. Systemic diseases associated with nonarteritic anterior ischemic optic neuropathy. Am J Ophthalmol. 1994;118:766-780.
10. Hayreh SS, Podhajsky PA, Zimmerman B. Nonarteritic anterior ischemic optic neuropathy: Time of onset of visual loss. Am J Ophthalmol. 1997;124:641-647.
11. Hayreh SS, Zimmerman MB, Podhajsky P, Alward WL. Nocturnal arterial hypotension and its role in optic nerve head and ocular ischemic disorders. Am J Ophthalmol. 1994;117:603-624.
12. Hayreh SS, Podhajsky P, Zimmerman MB. Role of nocturnal arterial hypotension in optic nerve head ischemic disorders. Ophthalmologica. 1999;213:76-96. (Pubitemid 29049393)
13. Hayreh SS, Podhajsky PA, Zimmerman B. Ipsilateral recurrence of nonarteritic anterior ischemic optic neuropathy. Am J Ophthalmol. 2001;132:734-742.
14. Hayreh SS. Acute ischemic disorders of the optic nerve: Pathogenesis, clinical manifestations and management. Ophthalmol Clin North Am. 1996;9:407-442.
15. Hayreh SS. Inter-individual variation in blood supply of the optic nerve head. Its importance in various ischemic disorders of the optic nerve head, and glaucoma, low-tension glaucoma and allied disorders. Doc Ophthalmol. 1985;59:217-246.
16. Lieberman MF, Shahi A, Green WR. Embolic ischemic optic neuropathy. Am J Ophthalmol. 1978;86:206-210.
17. Hayreh SS, Zimmerman MB. Nonarteritic anterior Ischaemic optic neuropathy: Natural history of visual outcome. Ophthalmology. 2008;115:298-305. e2.
18. Hayreh SS, Zimmerman B. Visual deterioration in giant cell arteritis patients while on high doses of corticosteroid therapy. Ophthalmology. 2003;110:1204-1215.
19. Hayreh SS, Zimmerman B, Kardon RH. Visual improvement with corticosteroid therapy in giant cell arteritis. Report of a large study and review of literature. Acta Ophthalmol Scand. 2002;80:355-367.
20. Beck RW, Hayreh SS, Podhajsky PA, Tan ES, Moke PS. Aspirin therapy in nonarteritic anterior ischemic optic neuropathy. Am J Ophthalmol. 1997;123:212-217.
21. Newman NJ, Scherer R, Langenberg P, Kelman S, Feldon S, Kaufman D, Dickersin K, ischemic Optic Neuropathy Decompression Trial Research Group. The fellow eye in NAION: Report from the ischemic optic neuropathy decompression trial follow-up study. Am J Ophthalmol. 2002;134:317-328.
22. Dagenais GR, Yi Q, Lonn E, Sleight P, Ostergren J, Yusuf S, HOPE Trial Investigators. Impact of cigarette smoking in high-risk patients participating in a clinical trial. A substudy from the Heart Outcomes Prevention Evaluation (HOPE) trial. Eur J Cardiovasc Prev Rehabil. 2005;12:75-81.
23. Salomon O, Huna-Baron R, Kurtz S, Steinberg DM, Moisseiev J, Rosenberg N, Yassur I, Vidne O, Zivelin A, Gitel S, Davidson J, Ravid B, Seligsohn U. Analysis of prothrombotic and vascular risk factors in patients with nonarteritic anterior ischemic optic neuropathy. Ophthalmology. 1999;106:739-742.
24. Abu-Amero KK, Bosley TM. Prothrombotic and atherosclerotic risk factors lack significance in NAION patients harbouring mitochondrial DNA mutations. Br J Ophthalmol. 2006;90:119-120.
25. Hayreh SS. Non-arteritic anterior ischemic optic neuropathy and thrombophilia. Graefes Arch Clin Exp Ophthalmol. 2009;247:577-581.
26. Bull GM. Meteorological correlates with myocardial and cerebral infarction and respiratory disease. Br J Prev Soc Med. 1973;27:108-113.
27. Bull GM, Morton J. Environment, temperature and death rates. Age Ageing. 1978;7:210-224.
28. Clark CV. Seasonal variation in incidence of brachial and femoral emboli. Br Med J (Clin Res Ed). 1983;287:1109.
29. Kosmorsky G, Straga J, Knight C, Dagirmanjian A, Davis DA. The role of transcranial Doppler in nonarteritic ischemic optic neuropathy. Am J Ophthalmol. 1998;126: 288-290.
30. Stiebel-Kalish H, Hasanreisoglu M, Leibovici L. Aspirin following non-arteritic ischaemic optic neuropathy-a systematic review and metanalysis. Neuro-ophthalmol. 2010; 34:14-19.
31. Kupersmith MJ, Frohman L, Sanderson M, Jacobs J, Hirschfeld J, Ku C, Warren FA. Aspirin reduces the incidence of second eye NAION: A retrospective study. J Neuroophthalmol. 1997;17:250-253.
32. Salomon O, Huna-Baron R, Steinberg DM, Kurtz S, Seligsohn U. Role of aspirin in reducing the frequency of second eye involvement in patients with non-arteritic anterior ischaemic optic neuropathy. Eye (Lond). 1999;13 (Pt 3a):357-359.
33. Beck RW, Hayreh SS. Role of aspirin in reducing the frequency of second eye involvement in patients with nonarteritic anterior ischaemic optic neuropathy. Eye (Lond). 2000;14(Pt 1):118.